Resolution of synovitis and arrest of catabolic and anabolic bone changes in patients with psoriatic arthritis by IL-17A blockade with secukinumab: results from the prospective PSARTROS study

Overview of attention for article published in Arthritis Research & Therapy, July 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (73rd percentile)

Mentioned by

news: 1 news outlet

Citations

dimensions_citation: 62 Dimensions

Readers on

mendeley: 94 Mendeley

Summary News Dimensions citations

So far, Altmetric has seen 1 news story.

Secukinumab may reduce synovial inflammation in PsA patients

medwireNews, 03 Aug 2018

03-08-2018 | Rheumatology | News | Article medwireNews: Treatment with the interleukin (IL)-17A inhibitor secukinumab is…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.